Solarea Bio is a preclinical-stage biotechnology company in Cambridge, MA developing new microbiome-based solutions to some of the world’s largest health problems. Solarea was founded in 2017 by a group of scientists and entrepreneurs eager to radically alter our understanding of the human microbiome and utilize its power to improve human health. The Solarea breakthrough came from the combined efforts of the company’s co-founders who established a link between the discovery of an untapped source of microorganisms with probiotic potential in healthy foods, and their applications in inflammatory processes including the gut-musculoskeletal axis. Using powerful genomic and bioinformatic tools, Solarea is mining its novel microbial strain collection to identify synergistic combinations of microbes and prebiotic plant fibers to develop solutions for patients suffering from inflammatory processes.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $26.2M
Founded date: 2017
Investors 3
Date | Name | Website |
- | Joyance Pa... | joyancepar... |
- | S2G Ventur... | s2gventure... |
- | Tencent | tenx.tc |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
17.05.2023 | Series B | $15M | Bold Capit... | builtinbos... |
19.10.2020 | Series A | $11.2M | - | vcnewsdail... |
Mentions in press and media 12
Date | Title | Description | Source |
17.05.2023 | Solarea Bio Raises $15M, Gingko Joins Partnership, and More ... | Photo: Shutterstock Biotech has long been a bustling sector in the Bay State, with universities, re... | builtinbos... |
08.05.2023 | Solarea Bio Holds First $15M Close of Series B Financing | Solarea Bio, a Cambridge, MA-based clinical stage biotechnology company, raised $15M in Series B fun... | finsmes.co... |
08.05.2023 | Solarea Bio Announces $15M in Series B Financing | CAMBRIDGE, MA, Solarea Bio,announced first closing of $15M in Series B financing. >> Click ... | vcnewsdail... |
02.10.2022 | The Motivation Behind our Microbiome Focus | Photo by CDC on Unsplash Scientific exploration of the microbiome represents the opening of one of ... | joyancepar... |
19.10.2021 | Solarea Bio : Announces Licensing Agreement with ADM | CAMBRIDGE, Mass., Oct. 19, 2021 /PRNewswire/ -- Solarea Bio, a biotech company based in Cambridge, M... | marketscre... |
19.10.2020 | Solarea Bio Announces Series A Financing Led by S2G Ventures... | CAMBRIDGE, Mass., Oct. 19, 2020 /PRNewswire/ -- Solarea Bio, a biotech company based in Cambridge,... | prnewswire... |
19.10.2020 | Solarea Bio Raises $11.2M in Series A Financing | Solarea Bio, a Cambridge, MA-based biotech company developing microbial-based solutions to aid human... | finsmes.co... |
19.10.2020 | Solarea Bio Raises $11.2M in Series A | Solarea Bio, a biotech company based in Cambridge, MA developing microbial-based solutions to aid hu... | citybizlis... |
19.10.2020 | Solarea Bio Announces $11.2M in Series A | CAMBRIDGE, MA, Solarea Bio announced it has raised $11.2M in a Series A financing led by S2G Ventu... | vcnewsdail... |
19.10.2020 | The Crunchbase News Briefing: Mon., Oct. 19 | 4 Shares Email Facebook Twitter LinkedIn Here’s what you need to know today in startup and venture ... | news.crunc... |
Show more